BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 26451526)

  • 1. iPS Cell-Derived Immunosuppressive Myeloid Cells.
    Zavazava N
    Transplantation; 2015 Nov; 99(11):2245-6. PubMed ID: 26451526
    [No Abstract]   [Full Text] [Related]  

  • 2. New Immunosuppressive Cell Therapy to Prolong Survival of Induced Pluripotent Stem Cell-Derived Allografts.
    Sasaki H; Wada H; Baghdadi M; Tsuji H; Otsuka R; Morita K; Shinohara N; Seino K
    Transplantation; 2015 Nov; 99(11):2301-10. PubMed ID: 26360665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of primary and metastatic liver cancer by human iPS cell-derived myeloid cells producing interferon-β.
    Sakisaka M; Haruta M; Komohara Y; Umemoto S; Matsumura K; Ikeda T; Takeya M; Inomata Y; Nishimura Y; Senju S
    J Hepatobiliary Pancreat Sci; 2017 Feb; 24(2):109-119. PubMed ID: 28008721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. iPSC-MSCs and islet allograft tolerance.
    Wang TS; Cheng PP; Qi ZQ
    Oncotarget; 2015 May; 6(13):10669-70. PubMed ID: 26027882
    [No Abstract]   [Full Text] [Related]  

  • 5. Transplantation: new protocols and new worries.
    Grinyo JM
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):192-7. PubMed ID: 19237802
    [No Abstract]   [Full Text] [Related]  

  • 6. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
    Zhang W; Liang S; Wu J; Horuzsko A
    Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical immunosuppressive regimens and clinical results in renal transplantation.
    Bertolatus JA
    Semin Nephrol; 1992 Jul; 12(4):332-42. PubMed ID: 1410861
    [No Abstract]   [Full Text] [Related]  

  • 8. Induced pluripotent stem cell-based therapy for age-related macular degeneration.
    Bracha P; Moore NA; Ciulla TA
    Expert Opin Biol Ther; 2017 Sep; 17(9):1113-1126. PubMed ID: 28664762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limb transplantation in rats: immunosuppression with FK-506.
    Min Z; Jones NF
    J Hand Surg Am; 1995 Jan; 20(1):77-87. PubMed ID: 7536766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How regenerative medicine may contribute to the achievement of an immunosuppression-free state.
    Orlando G; Wood KJ; Soker S; Stratta RJ
    Transplantation; 2011 Oct; 92(8):e36-8; author reply e39. PubMed ID: 21989270
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of thymoglobulin induction therapy in the prevention of acute graft rejection episodes following liver transplantation.
    Tchervenkov J; Flemming C; Guttmann RD; des Gachons G
    Transplant Proc; 1997 Nov; 29(7A):13S-15S. PubMed ID: 9366919
    [No Abstract]   [Full Text] [Related]  

  • 12. New insights into renal transplantation.
    Lebranchu Y
    Curr Opin Organ Transplant; 2010 Aug; 15(4):449-50. PubMed ID: 20631614
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunosuppression for lung transplantation.
    Bhorade SM; Stern E
    Proc Am Thorac Soc; 2009 Jan; 6(1):47-53. PubMed ID: 19131530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact areas in pediatric transplantation.
    Mazariegos GV
    Curr Opin Organ Transplant; 2011 Oct; 16(5):476. PubMed ID: 21900777
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosuppression in the era of biological agents.
    Grinyó JM; Cruzado JM; Bestard O; Vidal Castiñeira JR; Torras J
    Adv Exp Med Biol; 2012; 741():60-72. PubMed ID: 22457103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Renal transplantation].
    Hasegawa A
    Nihon Jinzo Gakkai Shi; 2003; 45(1):12-9. PubMed ID: 12680315
    [No Abstract]   [Full Text] [Related]  

  • 17. Implantation site-dependent differences for tracheal regeneration with induced pluripotent stem cells (iPS cells).
    Imaizumi M; Nomoto Y; Sugino T; Otsuki K; Omori K
    Acta Otolaryngol; 2013 Apr; 133(4):405-11. PubMed ID: 23675768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy.
    Talmadge JE
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5243-8. PubMed ID: 17875751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression in liver transplantation.
    Post DJ; Douglas DD; Mulligan DC
    Liver Transpl; 2005 Nov; 11(11):1307-14. PubMed ID: 16237688
    [No Abstract]   [Full Text] [Related]  

  • 20. An update on chemical pharmacotherapy options for the prevention of kidney transplant rejection with a focus on costimulation blockade.
    Kälble F; Schaier M; Schäfer S; Süsal C; Zeier M; Sommerer C; Morath C
    Expert Opin Pharmacother; 2017 Jun; 18(8):799-807. PubMed ID: 28460546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.